Holifya (private company)

See something wrong or missing? Let us know
Offices:Milano
Business model:B2B

Holifya is a Italian DNA analysis startup operating a platform for digital health and wellness with a personalized and scientific approach, based on your genetic profile, biomarkers, habits, and goals.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 528k


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Holifya

Name Criteria
United Kingdom Valink Therapeutics
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Signatur Biosciences
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Germany Atai Life Sciences
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 3
Switzerland Bionomous
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 3
United Kingdom iLoF
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 3
Sweden Monocl
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
Spain Naru Intelligence
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 3
United Kingdom Novai
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
Norway OncoImmunity
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
United Kingdom Sano Genetics
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
Top